Search
Pixantrone
go.drugbank.com/drugs/DB06193ApprovedWithdrawnPixantrone was designed to treat relapsed or refractory aggressive non-Hodgkin's lymphoma(NHL) in patients who have failed two prior lines of therapy. [2] For patients suffering from NHL, first line therapies … Pixantrone dimaleate, administered intravenously, was designed by Cell Therapeutics Incorporated as an alternative second line therapy in refractory or relapsed NHL.
Categories: Topoisomerase II InhibitorsArginine
go.drugbank.com/drugs/DB00125ApprovedInvestigationalNutraceuticalAn essential amino acid that is physiologically active in the L-form.
Mixtures: NUTRIPLUS LIPID SENZA ELETTROLITI, NUTRIPLUS LIPID SENZA ELETTROLITISerine
go.drugbank.com/drugs/DB00133ApprovedInvestigationalNutraceuticalA non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines; pyrimidines; and other amino acids.
Mixtures: NUTRIPLUS LIPID SENZA ELETTROLITI, NUTRIPLUS LIPID SENZA ELETTROLITIModerate to Severe Glabellar Frown Lines
go.drugbank.com/conditions/DBCOND0042188Synonyms: Moderate to Severe Glabellar Line, Moderate-severe Glabellar LinesAspartic acid
go.drugbank.com/drugs/DB00128ApprovedInvestigationalNutraceuticalOne of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
Mixtures: NUTRIPLUS LIPID SENZA ELETTROLITI, NUTRIPLUS LIPID SENZA ELETTROLITIDiabetic Ketoacidosis
go.drugbank.com/conditions/DBCOND0000979Synonyms: Ketoacidosis in diabetes mellitusSilver oxide
go.drugbank.com/drugs/DB15668InvestigationalSynonyms: Silver(I) oxideProducts: Fullerene Silver Ion Bacteriostatic SolutionAcute Myeloid Leukemia
go.drugbank.com/conditions/DBCOND0029883Drugs: Azacitidine · Cedazuridine · Cyclophosphamide · Cytarabine · Decitabine · Doxorubicin +9 moreSynonyms: Refractory anemia with excess blasts in transformation, Refractory anaemia with excess blasts in transformation